SERUM ISOFORM [-2]PROPSA DERIVATES (%P2PSA AND PHI) SIGNIFICANTLY IMPROVES THE PREDICTION OF PROSTATE CANCER AT INITIAL BIOPSY IN A TPSA RANGE 2-10 NG/ML. A MULTICENTRIC EUROPEAN STUDY

被引：0
|
作者：
Haese, Alexander
Lazzeri, Massimo
de la Taille, Alexandre
Palou, Joan
McNicholas, Thomas
Scattoni, Vincenzo
Lughezzani, Giovanni
Larcher, Alessandro
Lista, Giuliana
Cestari, Andrea
Renter, Anke
Bosset, Pierre Olivier
Le Corvoisier, Philippe
Fowler, Linda
Roux, Jacques William T.
Breda, Alberto
de la Torre, Pablo
Bini, Vittorio
Buffi, Nicolomaria
Guazzoni, Giorgio
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.2136
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2227
引用
收藏
页码：E913 / E914
页数：2
相关论文
共 43 条
  • [31] Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1
    Tan, Lincoln G. L.
    Tan, Yung Khan
    Tai, Bee Choo
    Tan, Karen M. L.
    Gauhar, Vineet
    Tiong, Ho Yee
    Hawkins, Robert C. W.
    Thamboo, Thomas P.
    Hong, Felicia S. K.
    Chiong, Edmund
    ASIAN JOURNAL OF ANDROLOGY, 2017, 19 (03) : 286 - 290
  • [32] Serum (-2)proPSA/freePSAratio, (-2)proPSA/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate-specific antigen 2-10 ng/mL
    Ferro, Matteo
    Crocetto, Felice
    La Civita, Evelina
    Fiorenza, Mariano
    Jannuzzi, Giuseppe
    Carbone, Gianluigi
    Sirica, Rosa
    Sicignano, Enrico
    Pagano, Giovanni
    Imbimbo, Ciro
    Terracciano, Daniela
    PROSTATE, 2024, 84 (12): : 1157 - 1164
  • [33] Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study
    Fossati, Nicola
    Buffi, Nicolo Maria
    Haese, Alexander
    Stephan, Carsten
    Larcher, Alessandro
    McNicholas, Thomas
    de la Taille, Alexandre
    Freschi, Massimo
    Lughezzani, Giovanni
    Abrate, Alberto
    Bini, Vittorio
    Palou Redorta, Joan
    Graefen, Markus
    Guazzoni, Giorgio
    Lazzeri, Massimo
    EUROPEAN UROLOGY, 2015, 68 (01) : 132 - 138
  • [34] Performance of a validated urine exosome gene expression test (EPI) in men within the USPSTF suggested age-group of 55 to 69 years at initial biopsy with a PSA 2-10 ng/mL.
    Donovan, Michael J.
    Noerholm, Mikkel
    Torkler, Phillipp
    Skog, Johan
    Margolis, Eric
    Brown, Gordon Andrew
    McKiernan, James M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [35] Prospective study on the performance of the prostate-specific antigen isoform P2PSA and its derivative prostate health index in prediction of prostate cancer in local Chinese men with total prostate-specific antigen levels of 410 ng/mL
    Tsang, Chiu-Fung
    Yiu, Ming Kwong
    Cheung, Fu-Keung
    Chiu, Yi
    Ho, Brian Sze-Ho
    Ng, Ada Tsui-Lin
    Wong, Jason Ka-Wing
    Wong, Charles Kam-Wai
    Poon, Vincent Yick-Kwan
    Ma, Wai-Kit
    Tsu, James Hok-Leung
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 : 62 - 62
  • [36] COMPARISON OF FREE-TO-TOTAL PSA RATIO, P2PSA-TO-FREE PSA RATIO AND PROSTATE HEALTH INDEX (PHI) IN THE PREDICTION OF PROSTATE BIOPSY OUTCOME IN PATIENTS WHO HAVE SERUM PSA LEVEL BETWEEN 4 TO 10 NG/ML RECEIVING FIRST TRANSRECTAL ULTRASOUND GUIDED BIOPSY
    Chi-Fai, N.
    Peter, K. F. C.
    Ny, L.
    Hc, L.
    Kim, W. M. L.
    Eddie, S.
    Simon, S. M. H.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 253 - 253
  • [37] A urine extracellular vesicle circRNA classifier for detection of high-grade prostate cancer in patients with prostate-specific antigen 2-10 ng/mL at initial biopsy
    He, Ya-Di
    Tao, Wen
    He, Tao
    Wang, Bang-Yu
    Tang, Xiu-Mei
    Zhang, Liang-Ming
    Wu, Zhen-Quan
    Deng, Wei-Ming
    Zhang, Ling-Xiao
    Shao, Chun-Kui
    Zhou, Jing
    Rong, Li-Min
    Gao, Xin
    Li, Liao-Yuan
    MOLECULAR CANCER, 2021, 20 (01)
  • [38] Measurement of serum isoform [-2]proPSA derivatives shows superior accuracy to magnetic resonance imaging in the diagnosis of prostate cancer in patients with a total prostate-specific antigen level of 2-10ng/ml
    Furuya, Kazuhiro
    Kawahara, Takashi
    Narahara, Masaki
    Tokita, Takashi
    Fukui, Sachi
    Imano, Masashi
    Mitome, Taku
    Ito, Yusuke
    Izumi, Koji
    Osaka, Kimito
    Yokomizo, Yumiko
    Hayashi, Narihiko
    Hasumi, Hisashi
    Nawata, Shintaro
    Kawano, Tsuyoshi
    Yao, Masahiro
    Uemura, Hiroji
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 (04) : 251 - 257
  • [39] Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml
    Ito, Kazuto
    Yokomizo, Akira
    Tokunaga, Shoji
    Arai, Gaku
    Sugimoto, Mikio
    Akakura, Koichiro
    Hasumi, Hisashi
    Sakai, Hideki
    Ouraji, Akiko
    Oki, Ryo
    Kashiwagi, Eiji
    Kobori, Yoshitomo
    Hirama, Hiromi
    Kitoh, Hiroki
    Uemura, Hiroji
    Hakariya, Tomoaki
    Suzuki, Kazuhiro
    JOURNAL OF UROLOGY, 2020, 203 (01): : 83 - 91
  • [40] Editorial comment on: Measurement of serum isoform [-2]proPSA derivatives shows superior accuracy to magnetic resonance imaging in the diagnosis of prostate cancer in patients with a total prostate-specific antigen level of 2-10ng/ml
    Abrate, Alberto
    Simonato, Alchiede
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 (04) : 258 - 259
12345